GGrantIndex
Sort

39,280 grants matching leukemia

Cellular and Molecular Studies of Bone Marrow Transplant

$1,512,059
James L M Ferrara · University Of Michigan At Ann Arbor · P01 · FY2007 · CA

Development of Innovative Resources to Advance MDS Research

$1,511,993
Marie Bleakley · Fred Hutchinson Cancer Center · RC2 · FY2024 · DK

Adoptive T cell Therapy for Pediatric Leukemia

$1,511,241
Terry Fry · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Support for Human Specimen Banking in NCI-Sponsored Clinical Trials-(CGB)

$1,510,732
Nilsa Del Carmen Ramirez · Research Inst Nationwide Children'S Hosp · U24 · FY2014 · CA

Hematopoietic Stem Cell Transplant for GATA2 Deficiency

$1,510,264
Dennis Hickstein · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

BIOLOGY AND TRANSPLANTATION OF THE HUMAN STEM CELL

$1,509,110
University Of Minnesota Twin Cities · P01 · FY2003 · CA

Etiology of Treatment Induced Secondary Leukemia

$1,508,297
Michelle M Le Beau · University Of Chicago · P01 · FY2007 · CA

Studies of Populations Exposed to Environmental Sources of Radiation

$1,507,082
Kiyohiko Mabuchi · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA

Pathogenesis of ETV6-Related Acute Lymphoblastic Leukemia

$1,506,693
Kim Erika Nichols · St. Jude Children'S Research Hospital · R01 · FY2020 · CA

ETIB Clinical Trials

$1,506,520
Ronald Gress · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Temporal & spatial organization of signaling complexes in T & B Cells

$1,503,262
Gary A. Koretzky · University Of Pennsylvania · P01 · FY2011 · CA

Studies in the Pathogenesis of Systemic Capillary Leak Syndrome

$1,503,131
Kirk Druey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

HEMATOPOIETIC STEM CELLS FOR TRANSPLANTATION

$1,502,960
Johns Hopkins University · P01 · FY2000 · CA

Life and Longevity After Cancer (LILAC): The Women's Health Initiative Cancer Survivor Cohort

$1,502,372
Garnet L. Anderson · Fred Hutchinson Cancer Center · U01 · FY2022 · CA

ONCOGENE DEREGULATION/TUMOR SUPPRESSOR GENE LOSS IN CLL

$1,501,186
Thomas Jefferson University · P01 · FY2001 · CA

CLINICAL PHARMACOKINETICS AND SAFETY TRIALS IN DOWN SYNDROME

$1,500,903
Mara Becker · Duke University · N01 · FY2021 · HD

GENOME SEQUENCING OF ASPERGILLUS FUMIGATUS

$1,500,037
University Of Manchester · U01 · FY2001 · AI

Support for Human Specimen Banking in NCI-Sponsored Clinical Trials-(CGB)

$1,500,000
Nilsa Del Carmen Ramirez · Research Inst Nationwide Children'S Hosp · U24 · FY2012 · CA

GENOME SEQUENCING OF ASPERGILLUS FUMIGATUS

$1,500,000
University Of Manchester · U01 · FY2000 · AI

Children's Oncology Group NCI Community Oncology Research Program (NCORP) Research Base grant

$1,500,000
Michael E. Roth · Public Health Institute · UG1 · FY2023 · CA

IGF::OT::IGF: SBIR PHASE II, TOPIC 326: DEVELOPMENT OF NOVEL THERAPEUTIC AGENTS THAT TARGET CANCER STEM CELLS

$1,499,999
Dr. Tzuyin (cindy) Lin · Lp Therapeutics, Inc. · N44 · FY2016 · CA

IGF::CT::IGF DEVELOPMENT OF PRAEDICARE DX AS CDX FOR AMLPERIOD OF PERFORMANCE: SEPTEMBER 19, 2014 THROUGH SEPTEMBER 18, 2015

$1,499,743
Michael Cardone · Eutropics Pharmaceuticals, Inc. · N44 · FY2014 · CA

ETIB Clinical Research Core

$1,498,841
Ronald Gress · Division Of Basic Sciences - Nci · ZID · FY2021 · CA

Defining and Manipulating Epigenomic Regulators in Endogenous Systems

$1,498,670
Jordan Leslie Meier · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Genetic Aspects Of Viral Oncogenesis In Inbred Strains and Wild Mouse Species

$1,497,550
Christine Kozak · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI